ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP10

Breaking Through Scleroderma’s Invisible Struggles: From Isolation to Connection

Sheri Hicks, Mary Alore

Meeting: ACR Convergence 2025

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (PP09-PP13) Patient Perspectives

Session Type: Patient Perspectives

Session Time: 8:30AM-8:45AM

Background/Purpose: While living in Tucson, Arizona in 2006, and caring to our 1-year-old son, I noticed painful ulcers on my red, swollen, and tight fingertips. The pain became unbearable, and it took nearly 6 months before I finally diagnosed with scleroderma in 2007. I could hardly pronounce or understand the word, but I knew I couldn’t ignore it. After reaching a point of exhaustion, we relocated to Michigan to be with family and friends. That move became a turning point. In Michigan, I found a supportive community and discovered a new purpose. Although I can no longer work full-time, I became a patient partner in research to help make sure patients’ voices are reflected in studies. I am also a trained peer mentor and find joy in connecting with others living with scleroderma. By sharing my experiences, I hope others feel less alone in what can be an isolating journey. This work has given me a renewed purpose, and I am dedicated to supporting others on their journey with scleroderma.

Intervention: Living with a rare disease like scleroderma can be isolating, especially when symptoms are invisible to others and we “don’t look sick.”  This invisibility can make it hard to manage daily life and feel understood. I’ve found that combining peer support and building a strong community connections help address not just the physical symptoms, but also the emotional and social toll of living with scleroderma. As a trained peer mentor and a peer health coach in the RENEW (Resilience-building Energy management to Enhance Well-being) intervention, I’ve supported others in building resilience and managing energy to improve their quality of life. I also co-founded Scleroderma Backers, an online community that support patients with nearly 900 members, which offers a safe space for connection, questions, and shared understanding. Through RENEW and Scleroderma Backers, I’ve seen how support from those who “get it” can foster hope and promote health behaviors.

Maintenance: Through ongoing connections, whether in RENEW, the Scleroderma Backers, or extended community, I’ve learned to better advocate for myself, adjust to changing roles, and stay engaged in my care. These non-clinical approaches have strengthened my well-being, increased my confidence in navigating daily challenges, and reduced feelings of isolation.

Quality of Life: Today, my quality of life is much more balanced and fulfilling than it was at the time of my diagnosis. While I still face daily challenges from scleroderma, I’ve learned how to manage my symptoms, set realistic goals, and lean on a strong support system. Being actively involved in peer support and patient-centered research gives me purpose and connection that empowers and inspires me to help others on their journey.

Takeaway: This abstract highlights the importance of integrating peer support into care to inspire self-care, foster meaningful connections, and reduce isolation. It also emphasizes the value of comprehensive care that support overall well-being. As patients find innovative ways to manage their conditions, healthcare providers are crucial in promoting these strategies. These insights benefit various rheumatic conditions, strengthening support systems that empower patients and enhance overall well-being.


Disclosures: S. Hicks: None; M. Alore: None

To cite this abstract in AMA style:

Hicks S, Alore M. Breaking Through Scleroderma’s Invisible Struggles: From Isolation to Connection [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/breaking-through-sclerodermas-invisible-struggles-from-isolation-to-connection/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/breaking-through-sclerodermas-invisible-struggles-from-isolation-to-connection/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology